Transforming 5-nonyloxytryptamine and Epirubicin into Polysialic Acid Mimetics: A Breakthrough in Protecting Human Neuronal Cells from MPP+-Induced Toxicity
Recent advancements in the field of neurodegenerative disease research have revealed a promising new avenue for the treatment of Parkinson’s ...
